Previous company |
CE Mark (Regyn Product) - European Scientific League of Probiotics (ESLP)
VESALE PHARMA developed a full range of products for all life stages. Its portfolio covers three therapeutic fields: a) The pediatric products with mainly the Bacilac Infantis range - B) The women health range and c) The adult range. New products will be launched in 2019.
VESALE PHARMA dedicates 23% of turnover in R&D every year and is developing applied & fundamental researches in fields of probiotic therapy and technology as well as of applied metabolomics and phagotherapy. VESALE works on with major Belgian and international Universities or Institute, e.g. the Institut Pasteur of Lille (France) and Texas A&M University (USA). Among the six patents, the patent Intelicaps® is a world unique revolutionary technology of probiotics micro-encapsulation that give a much higher value and efficacy to the probiotic solutions compared with the competitors' products.